Hand hygiene for the prevention of infections in neonates.
Bankole Peter Kuti,Tinuade A Ogunlesi,Olabisi Oduwole,Chukwudi Oringanje,Ekong E Udoh,Martin M Meremikwu
DOI: https://doi.org/10.1002/14651858.CD013326.pub2
IF: 8.4
2021-01-22
Cochrane Database of Systematic Reviews
Abstract:Annually, infections contribute to approximately 25% of the 2.8 million neonatal deaths worldwide. Over 95% of sepsis‐related neonatal deaths occur in low‐ and middle‐income countries. Hand hygiene is an inexpensive and cost‐effective method of preventing infection in neonates, making it an affordable and practicable intervention in low‐ and middle‐income settings. Therefore, hand hygiene practices may hold strong prospects for reducing the occurrence of infection and infection‐related neonatal death. To determine the effectiveness of different hand hygiene agents for preventing neonatal infection in community and health facility settings. We used the standard search strategy of Cochrane Neonatal to search the Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 5), in the Cochrane Library; MEDLINE via PubMed (1966 to 10 May 2019); Embase (1980 to 10 May 2019); and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (1982 to 10 May 2019). We also searched clinical trials databases and the reference lists of retrieved articles for randomised controlled trials (RCTs) and quasi‐randomised trials. Searches were updated 1 June 2020. We included RCTs, cross‐over trials, and quasi‐RCTs that included pregnant women, mothers, other caregivers, and healthcare workers who received interventions within the community or in health facility settings We used standard methodological procedures expected by Cochrane and the GRADE approach to assess the certainty of evidence. Primary outcomes were incidence of (study author‐defined) suspected infection within the first 28 days of life, bacteriologically confirmed infection within the first 28 days of life, all‐cause mortality within the first seven days of life (early neonatal death), and all‐cause mortality from the 8th to the 28th day of life (late neonatal death). Our review included five studies: one RCT, one quasi‐RCT, and three cross‐over trials with a total of more than 5450 neonates (two studies included all neonates but did not report the actual number of neonates involved). Four studies involved 279 nurses working in neonatal intensive care units and all neonates on admission. The fifth study did not clearly state how many nurses were included in the study. Studies examined the effectiveness of different hand hygiene practices for the incidence of (study author‐defined) suspected infection within the first 28 days of life. Two studies were rated as low risk for selection bias, another two were rated as high risk, and one study was rated as unclear risk. One study was rated as low risk for allocation bias, and four were rated as high risk. Only one of the five studies was rated as low risk for performance bias. 4% chlorhexidine gluconate (CHG) compared to plain liquid soap We are uncertain whether plain soap is better than 4% chlorhexidine gluconate (CHG) for nurses' skin based on very low‐certainty evidence (mean difference (MD) ‐1.75, 95% confidence interval (CI) ‐3.31 to ‐0.19; 16 participants, 1 study; very low‐certainty evidence). We identified no studies that reported on other outcomes for this comparison. 4% chlorhexidine gluconate compared to triclosan 1% One study compared 1% w/v triclosan with 4% chlorhexidine gluconate and suggests that 1% w/v triclosan may reduce the incidence of suspected infection (risk ratio (RR) 1.04, 95% CI 0.19 to 5.60; 1916 participants, 1 study; very low‐certainty evidence). There may be fewer cases of infection in the 1% w/v triclosan group compared to the 4% chlorhexidine gluconate group (RR 6.01, 95% CI 3.56 to 10.14; 1916 participants, 1 study; very low‐certainty evidence); however, we are uncertain of the available evidence. We identified no study that reported on all‐cause mortality, duration of hospital stay, and adverse events for this comparison. 2% CHG compared to alcohol hand sanitiser (61% alcohol and emollients) We are uncertain whether 2% chlorhexidine gluconate reduces the risk of all infection in neonates compared to 61% alcohol hand sanitiser with regards to the incidence of all bacteriologically confirmed infection within the first 28 days of life (RR 2.19, 95% CI 1.79 to 2.69; 2932 participants, 1 study; very low‐certainty evidence) in the 2% chlorhexidine gluconate group, but the evidence is very uncertain. The adverse outcome was reported as mean visual scoring on the skin. There may be little to no difference between the effects of 2% CHG on nurses' skin compared to alcohol hand sanitiser based on very low‐certainty evidence (MD 0.80, 95% CI 0.01 to 1.59; 118 participants, 1 study; very low‐certainty evidence). We identified no study that reported on all‐cause mortality and other outcomes for this comparison. None of the included studies assessed all‐cause mortality within the first seven days of life nor duration of hospital stay. We are uncertain as to the superi -Abstract Truncated-
medicine, general & internal